These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22834013)

  • 21. The role of drug transporters at the blood-brain barrier.
    de Boer AG; van der Sandt IC; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2003; 43():629-56. PubMed ID: 12415123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R; Decleves X; Scherrmann JM
    Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening.
    Kadoguchi M; Arakawa H; Honda R; Hotta K; Shirasaka Y; Deguchi Y; Tamai I
    Pharm Res; 2022 Jul; 39(7):1549-1559. PubMed ID: 35314999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transporters in the brain endothelial barrier.
    Ueno M; Nakagawa T; Wu B; Onodera M; Huang CL; Kusaka T; Araki N; Sakamoto H
    Curr Med Chem; 2010; 17(12):1125-38. PubMed ID: 20175745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transporter-mediated permeation of drugs across the blood-brain barrier.
    Tamai I; Tsuji A
    J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The blood-brain barrier choline transporter as a brain drug delivery vector.
    Allen DD; Lockman PR
    Life Sci; 2003 Aug; 73(13):1609-15. PubMed ID: 12875893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of brain choline uptake by isoarecolone and lobeline derivatives: implications for potential vector-mediated brain drug delivery.
    Metting TL; Burgio DE; Terry AV; Beach JW; McCurdy CR; Allen DD
    Neurosci Lett; 1998 Dec; 258(1):25-8. PubMed ID: 9876043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
    Okura T; Higuchi K; Deguchi Y
    Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo upregulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides.
    Boado RJ; Wu D; Windisch M
    Neurosci Res; 1999 Sep; 34(4):217-24. PubMed ID: 10576544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug penetration across the blood-brain barrier: an overview.
    Mangas-Sanjuan V; González-Alvarez M; Gonzalez-Alvarez I; Bermejo M
    Ther Deliv; 2010 Oct; 1(4):535-62. PubMed ID: 22833966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contributions of Drug Transporters to Blood-Brain Barriers.
    Liu L; Liu X
    Adv Exp Med Biol; 2019; 1141():407-466. PubMed ID: 31571171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and Metabolic Integrity of the Blood-Brain Barrier in HIV Infection: A Special Focus on Intercellular Junctions, Influx and Efflux Transporters and Metabolizing Enzymes.
    Shawahna R
    Curr Drug Metab; 2015; 16(2):105-23. PubMed ID: 26179607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABC transporters and drug efflux at the blood-brain barrier.
    Shen S; Zhang W
    Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
    Abdullahi W; Davis TP; Ronaldson PT
    AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
    Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
    Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Nicotine Transport across the Blood-Brain Barrier: Carrier-Mediated Transport of Nicotine and Interaction with Central Nervous System Drugs.
    Tega Y; Yamazaki Y; Akanuma SI; Kubo Y; Hosoya KI
    Biol Pharm Bull; 2018; 41(9):1330-1336. PubMed ID: 30175770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier].
    Jacob A; Declèves X; Scherrmann JM
    Biol Aujourdhui; 2012; 206(3):177-83. PubMed ID: 23171840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
    Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
    Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of efflux transporters in the brain on the development of drugs for CNS disorders.
    Taylor EM
    Clin Pharmacokinet; 2002; 41(2):81-92. PubMed ID: 11888329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.